BOSTON, Dec. 6, 2010 /PRNewswire/ — PAREXEL International
Corporation (Nasdaq:
PRXL), a leading global biopharmaceutical services provider,
today announced that it has opened two new Clinical Logistics
Services facilities in emerging regions for biopharmaceutical
development. PAREXEL’s new depot in Singapore
and ancillary warehouse in Russia will support its clients in more
effectively managing their global clinical trial supply
requirements. These facilities serve as an extension of
PAREXEL’s existing infrastructure of depots and ancillary
warehouses based throughout North America, Latin America, Europe,
and Africa, as well the Asia/Pacific region.
With one of the largest and most comprehensive clinical research
organizations in Eastern Europe and the Asia/Pacific
region, PAREXEL has further strengthened its ability
to meet the
Clinical Logistics Services needs of its
clients through the addition of these new facilities.
The new depot in Singapore handles the distribution of
investigational medicinal products and non-investigational
medicinal products, as well as ancillary supplies needed for
clinical trials conducted by PAREXEL. The Company’s new
ancillary warehouse in Russia is intended to store any non-drug
material required for clinical trials in Russia, including lab
kits, drug application material, and medical supplies and
equipment, as well as documents, such as patient diaries and
questionnaires. The new facilities feature 24/7/365
monitoring systems, and provide a number of services to PAREXEL’s
clients including inventory management, as well as return and
destruction capabilities.
“The opening of these new facilities within our global
Clinical Logis
‘/>”/>
SOURCE